Accessibility StatementSkip Navigation NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our t ...

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex- ...

LOS ANGELES--(BUSINESS WIRE)--Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX. ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, alleging that these companies made materially false and misleading statements regarding their business operations and prospects [1]. Group 1: PubMatic, Inc. (NASDAQ: PUBM) - The class period for PubMatic is from February 27, 2025, to August 11, 2025, with a lead plaintiff deadline of October 20, 2025 [2]. - Allegations include failure to disclose a significant shift of clients to a new platform by a top DSP buyer, resulting in reduced ad spend and revenue for PubMatic [2]. - Defendants' positive statements about the company's business were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Snap Inc. (NYSE: SNAP) - The class period for Snap is from April 29, 2025, to August 5, 2025, with a lead plaintiff deadline of October 20, 2025 [3]. - The complaint alleges that Snap's optimistic reports on advertising growth were misleading, as they relied too heavily on the company's execution capabilities [3]. - Defendants failed to disclose significant execution errors and macroeconomic challenges, leading to materially misleading statements about the company's prospects [3]. Group 3: Nutex Health Inc. (NASDAQ: NUTX) - The class period for Nutex is from August 8, 2024, to August 14, 2025, with a lead plaintiff deadline of October 21, 2025 [4]. - Allegations include engaging in a scheme to defraud insurance companies, leading to unsustainable revenue claims [4]. - The company overstated its ability to remediate internal control weaknesses, resulting in improper accounting of stock-based compensation obligations [4]. Group 4: C3.ai, Inc. (NYSE: AI) - The class period for C3.ai is from February 26, 2025, to August 8, 2025, with a lead plaintiff deadline of October 21, 2025 [6]. - The complaint alleges that the company's optimistic growth reports were misleading, relying heavily on the CEO's health and effectiveness [6]. - Defendants failed to disclose that the CEO had not sufficiently recovered to fulfill his role, leading to materially misleading statements about the company's prospects [6].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 Â (Ext. 1310). [You may also click here for additional information] NEW YORK Â , Sept. ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex- ...

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased Nutex Health Inc. ("Nutex†or the "Company†) (NASDAQ:NUTX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Nutex investments, you have until October 21, 2025 to request lead plaintiff appointment. Follow the l. ...

Core Viewpoint - Nutex Health Inc. is facing legal challenges due to a class-action lawsuit alleging deceptive billing practices that artificially inflated its financial results [1][2][9]. Group 1: Legal Allegations - The lawsuit claims Nutex collaborated with HaloMD to submit ineligible insurance claims, misleading shareholders and causing significant financial losses [1][2]. - Allegations include a systematic effort to exploit the insurance arbitration process, with thousands of questionable claims submitted to extract outsized reimbursements [2][3]. - The lawsuit asserts that Nutex's revenue model is unstable and that financial statements did not accurately reflect the company's operations [2]. Group 2: Market Reaction - Following the release of a report by Blue Orca Capital, which accused HaloMD of a fraudulent scheme, Nutex's stock dropped over 10% [3][4]. - After Nutex announced a delay in its Form 10-Q filing, shares plunged 16.39%, closing at $92.91 [6]. Group 3: Financial Reporting Issues - Nutex is accused of misrepresenting its internal control progress, particularly in misclassifying stock-based compensation obligations [5]. - The Audit Committee determined that prior financial statements required restatement due to incorrect classification of obligations related to hospital development [7]. Group 4: Investor Impact - The class-action suit seeks damages for investors who acquired Nutex securities during the alleged misrepresentation period, claiming public disclosures were materially misleading [9]. - Hagens Berman is investigating whether Nutex's business model relied on questionable arbitration tactics and if its financial reporting misled investors [10].

Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, which has led to a class action lawsuit against the company [1]. Summary by Sections Allegations - The complaint alleges that Nutex Health engaged in a coordinated scheme to defraud insurance companies through its third-party vendor HaloMD, resulting in unsustainable revenues [1]. - The company overstated its ability to remediate material weaknesses in its internal controls over financial reporting, leading to improper accounting of stock-based compensation obligations [1]. - Nutex misclassified stock-based compensation obligations as equity instead of liabilities, increasing the risk of failing to file financial reports with the SEC on time [1]. - The allegations suggest that Nutex's business and financial prospects were overstated, making public statements materially false and misleading [1]. Class Action Details - Shareholders who purchased shares of Nutex during the specified class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].